Nuestro blog

The rapid expansion of the clinical research market in the Asia-Pacific (APAC) region has opened up significant prospects for carrying out decentralized clinical trials there.

Unstructured data collection from image capture technology can be harnessed to improve the quality of patient-reported data and serve as the bedrock for the training of new algorithms that can help clinicians more accurately diagnose disease.

Enhancing Electronic Patient-Reported Outcomes with digital instruments streamlines and accelerates data collection, making clinical trials more accessible.

This study collected and compared stool ratings from caregivers (Group A), central raters (Group B), and pediatric gastroenterologists (Group C) to discover whether the level of stool consistency of a given photo is more prone to inter-rater variability. The study's results evidence inter-rater variability that is different across Bristol Stool Scale (BSS), which motivates research into standardized training or automated scoring, with a special emphasis on BSS.

Moving into 2022, decentralized models, propelled by breakthroughs in digital technology, will continue to reshape the industry, improving trial outcomes.

Renovia needed a solution to evaluate the efficacy of its leva® Pelvic Health System for treating urinary incontinence, while ensuring ease of use for a busy female population. Of particular importance was enabling real-time symptom tracking and maintaining high patient engagement—without requiring in-person site visits.

In a recent study, we found that caregivers both underreported and overreported certain stool consistencies compared to clinician ratings. We need to make it easier for parents to report in clinical trials. See why digital image capture is an improved method for assessments of treatment efficacy and health status for pediatric GI research.

In the second of our two-part series, we explore how integrating mobile technology into study design can help attract and retain minorities and women as trial subjects.

With travel hampered and clinical trials disrupted, it’s difficult to conduct on-site clinical trial monitoring. The alternative — remote monitoring — has always made sense, but now this cost-effective, time-saving model is rightfully gaining steam. Remote monitoring in clinical trials means monitors don’t visit the site to transfer and review the data. Instead, the data monitoring is done virtually. With the use of digital technology, CROs and study sponsors/stakeholders can see the data from wherever they are located.

DCTs offer an effective avenue for studying what are sometimes considered “taboo” therapeutic areas while respecting participants’ discretion.